Company news
Shanghai Haohai Biological Technology Co., Ltd. Class A (SSE:688366) news
Shanghai Haohai Biological Technology Co., Ltd. Class A news releases on 6ix. Latest, Sep 14, 2026: "Shanghai Haohai Biological Technology Co.…
View Shanghai Haohai Biological Technology Co., Ltd. Class A →
Press releases & updates
"Shanghai Haohai Biological Technology Co., Ltd."Announcement on Adjustment of the Total Cash Dividend Amount for the 2026 Semi-annual Profit Distribution
September 13, 2026
"Shanghai Haohai Biological Technology Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry
September 7, 2026
"Shanghai Haohai Biological Technology Co., Ltd."Announcement on the Profit Distribution Plan for the First Half of 2026
August 21, 2026
"Shanghai Haohai Biological Technology Co., Ltd."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Trifocal Toric Intraocular Lens Product of the Controlled Subsidiary
August 6, 2026
Announcement on the Cancellation of Repurchased H Shares
June 22, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 10, 2026
Announcement on Voluntary Disclosure of the Holding Subsidiary’s Trifocal Intraocular Lens Product Obtaining the Medical Device Registration Certificate
June 2, 2026
Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution
June 1, 2026
Announcement on Notifying Creditors in Connection with the Repurchase of H-share Stocks
May 29, 2026
Announcement on Result of Shareholding Reduction by Shareholder
May 25, 2026
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
April 30, 2026
Notice on Convening the 2025 Annual General Meeting, the 1st Shareholders' Meeting of A Shares of 2026 and the 1st Shareholders' Meeting of H Shares of 2026
April 28, 2026
Report for Q1 2026
April 24, 2026
Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Multifocal Aspherical Intraocular Lens Product Obtaining the Medical Device Registration Certificate
April 7, 2026
Announcement on Provision for Asset Impairment for 2025
March 20, 2026
Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Intraocular Crosslinked Sodium Hyaluronate Gel Product Obtaining the Medical Device Registration Certificate
March 16, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Shareholding Reduction Plan for Shareholders
February 12, 2026
Indicative Announcement on Cancellation of Repurchased H-shares and the Passive Equity Change of Controlling Shareholder, Actual Controller and Its Persons Acting in Concert Reaching 1% Scale
December 29, 2025
Announcement on Receipt of the Decision for Administrative Penalty by One of the Company’s Controlling Shareholders and Actual Controllers Due to Non-company-related Matters
December 23, 2025
Announcement on Canceling SomeRestricted Stock Granted but Not Yet Vested in 2021 A-share Restricted Stock Incentive Plan
December 12, 2025
Announcement on Opening Special Settlement Account for Cash Management Products of Raised Funds
December 10, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 27, 2025
Announcement on Using Temporarily Idle Raised Funds for Cash Management
November 7, 2025
Report for Q3 2025
October 24, 2025
Announcement on Implementation of Semi-annual Dividend Distribution for 2025
October 9, 2025
Announcement on Receipt of the Prior Notice of Administrative Penalty by One of the Company’s Controlling Shareholders and Actual Controllers Due to Non-company-related Matters
September 16, 2025
Announcement on Attending Semi-annual Collective Performance Briefing for Enterprises in Biological Products and CXO Industries on SSE STAR Market 2025
September 5, 2025
Announcement on Semi-annual Profit Distribution Plan for 2025
August 22, 2025
Announcement on Voluntary Disclosure of Execution of Termination Agreement
August 20, 2025
Announcement on the Implementation Results of the Phase II of A-Share Stock Repurchase
August 15, 2025
Announcement on Progress in Phase II A-Share Repurchase through Call Auction
August 1, 2025
Announcement on Adjusting the Upper Limit of A-share Repurchase Price after Implementation of Dividend Distribution for 2024
June 30, 2025
Announcement on Shareholder Share Reduction Plan
June 24, 2025
Announcement on Implementation of Annual Dividend Distribution in 2024
June 23, 2025
Announcement on Necessary Notice to Creditors on H-shares Repurchase
June 13, 2025
Announcement on Adjusting the Total Cash Dividends for Profit Distribution in 2024
June 10, 2025
Notice on Convening the 2024 Annual General Meeting and the 1st A-share General Meeting in 2025 and the 1st H-share General Meeting in 2025
May 9, 2025
Announcement on Receipt of Notice of Case Filing by One of the Controlling Shareholders and Actual Controllers
May 7, 2025
Announcement on Progress in Repurchasing A-Shares through Call Auction in Phase II
May 6, 2025
Report for Q1 2025
April 25, 2025
Announcement on Change of Sponsor Representative for Continuous Supervision
April 11, 2025
Announcement on Resignation of Key Technical Personnel
March 28, 2025
Announcement on 2024 Annual Profit Distribution Plan
March 21, 2025
Announcement on Progress in Repurchasing A Shares through Call Auction in Phase II
March 3, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 19, 2025
Announcement on Resignation of Deputy General Manager and Key Technical Personnel
January 24, 2025
Announcement on Cancellation of Repurchased H Shares
December 30, 2024
Announcement on Convening the Q3 2024 Performance Briefing
December 3, 2024
Announcement on the Cancellation of Some Granted but Unvested Restricted Stocks under 2021 A-share Restricted Stock Incentive Plan
November 29, 2024